Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2018-03-20FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Tegretol (carbamazepine) filed by Novartis Pharmaceuticals Corporation, updating the labelin…
-
FDA approval · 2018-03-20FDA Approved: LEVETIRACETAM — Original Application (Method Pharmaceuticals, LLC)
FDA approved the original application for a generic levetiracetam product from Method Pharmaceuticals, LLC, authorizing its market entry as …
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: Study to Investigate Lacosamide as Add-on Therapy in Subjects ≥4 Years to <17 Years of Age With Partial Onset Seizures [Phase 3]
Phase 3 trial update for lacosamide as add-on therapy in children aged 4 to under 17 with partial onset seizures. The study has completed an…
-
CLINICAL_TRIALS withdrawal · 2018-03-15Clinical Trial Update: Transcranial Stimulation During Sleep to Improve Cognition in Epilepsy [NA]
A clinical trial evaluating transcranial stimulation during sleep to improve cognition in epilepsy has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-03-14Clinical Trial Update: Imaging Neuroinflammation in Epilepsy With Ferumoxytol MRI [NA]
A completed clinical trial (NCT02084303) evaluated using ferumoxytol-enhanced MRI to image neuroinflammation in epilepsy. The trial status i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-03-14Clinical Trial Update: A Complex Contraception Registry
This clinical trial update reports the completion of a complex contraception registry sponsored by the University of California, San Diego, …
-
FDA approval · 2018-03-13FDA Approved: VIGABATRIN — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal's generic version of vigabatrin under an Original Application (ANDA 210155), enabling marketing of the drug for its esta…
-
FDA approval · 2018-03-08FDA Approved: FOSPHENYTOIN SODIUM — Supplemental Application (West-Ward Pharmaceuticals Corp)
FDA approved a supplemental application for fosphenytoin sodium submitted by West-Ward Pharmaceuticals Corp. The action updates labeling for…
-
FDA approval · 2018-03-06FDA Approved: DEPAKOTE ER — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for Depakote ER (divalproex sodium) from AbbVie, authorizing changes to its labeling.
-
CLINICAL_TRIALS trial_result · 2018-03-06Clinical Trial Update: The Effect of Anti-epileptic Drugs on Mitochondrial Activity
A completed clinical trial assessing the effect of anti-epileptic drugs on mitochondrial activity in epilepsy.
-
CLINICAL_TRIALS trial_result · 2018-02-26Clinical Trial Update: Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS) [Phase 3]
Phase 3 long-term safety study of retigabine IR as adjunctive therapy for adults with partial-onset seizures has completed with results post…
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: Efficacy and Safety of Ketogenic Diet as Adjunctive Treatment in Adults With Refractory Epilepsy [Phase 2]
This document provides an update on a Phase 2 trial evaluating the efficacy and safety of a ketogenic diet as an adjunctive treatment for ad…
-
EMA safety_alert · 2018-02-09PRAC recommends new measures to avoid valproate exposure in pregnancy
The PRAC recommends new measures to prevent valproate exposure during pregnancy due to risks of birth defects and developmental problems in …
-
CLINICAL_TRIALS trial_result · 2018-02-05Clinical Trial Update: Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL)
A completed clinical trial evaluating serum FT4 and FT3 measurements in subjects treated with eslicarbazepine acetate (ESL).
-
FDA approval · 2018-01-29FDA Approved: LAMOTRIGINE KIT — Supplemental Application (OWP Pharmaceuticals, Inc.)
FDA approved a supplemental application for Lamotrigine Kit from OWP Pharmaceuticals, Inc.
-
CLINICAL_TRIALS withdrawal · 2018-01-16Clinical Trial Update: A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug [Phase 3]
A pediatric Phase 3 trial investigating long-term safety and tolerability of a drug for epilepsy has been withdrawn.
-
FDA approval · 2018-01-03FDA Approved: TROKENDI XR — Supplemental Application (Supernus Pharmaceuticals, Inc.)
FDA approved a supplemental application for TROKENDI XR (topiramate) from Supernus Pharmaceuticals, expanding the labeling of the extended-r…
-
FDA approval · 2017-12-29FDA Approved: LAMOTRIGINE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approves Alembic Pharmaceuticals Limited's supplemental application for lamotrigine chewable dispersible, expanding the approved generic…
-
FDA approval · 2017-12-27FDA Approved: GABAPENTIN — Supplemental Application (Creekwood Pharmaceuticals LLC)
The FDA approved a supplemental application for gabapentin submitted by Creekwood Pharmaceuticals LLC. The approval covers changes to an alr…
-
FDA approval · 2017-12-22FDA Approved: DILANTIN — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for DILANTIN (extended phenytoin sodium) from Viatris Specialty LLC.
-
FDA approval · 2017-12-22FDA Approved: PHENYTOIN INFATABS — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for Phenytoin Infatabs (phenytoin) submitted by Prasco Laboratories.
-
CLINICAL_TRIALS research · 2017-12-11Clinical Trial Update: The Management of Postoperative Craniotomy Pain in Pediatric Patients
A completed clinical trial managed by Johns Hopkins University evaluating postoperative pain management in pediatric craniotomy patients; th…
-
CLINICAL_TRIALS trial_result · 2017-11-30Clinical Trial Update: The Role of Melatonin in the Effective Attainment of Sleep Electroencephalograms (EEG) in Children [Phase 3]
Phase 3 trial evaluating whether melatonin helps children with epilepsy achieve sleep during EEG recordings.
-
CLINICAL_TRIALS research · 2017-11-30Clinical Trial Update: Omics-based Precision Medicine of Epilepsy
This document provides an update on a clinical trial exploring omics-based precision medicine approaches for epilepsy, sponsored by Fudan Un…
-
CLINICAL_TRIALS trial_result · 2017-11-28Clinical Trial Update: EEG@HOME (Phase 2 of the Project, Measurements in Healthy Volunteers) [NA]
A Phase 2 trial update for EEG@HOME evaluating at-home EEG measurements, completed in healthy volunteers, with epilepsy listed as the relate…